Source: Annual Congress 2004 - Trauma, interstitial disease and miscellaneous



Rating:

Share or cite this content

Citations should be made in the following way:
M. Takahama, K. Kushibe, M. Kimura, Y. Tamura, S. Taniguchi (Kashihara, Japan). Intravenous magnesium sulfate prophylaxis for atrial arrhythmias after pulmonary resection. Eur Respir J 2004; 24: Suppl. 48, 1109

Member's Comments

No comment yet.

Related content which might interest you: Anticoagulation in acute and chronic pulmonary embolism and atrial fibrillation Source: International Congress 2018 – PG19 Heart-lung interaction Year: 2018 Pulmonary embolism in noncoagulated patients with chronic atrial fibrillation at admission Source: Eur Respir J 2006; 28: Suppl. 50, 44s Year: 2006 The use of perioperative intravenous sildenafil in patients with mitral valve disease and co-existent pulmonary hypertension during cardiac surgery Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary veno-occlusive disease as a consequence of catheter ablation of atrial fibrillation Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001 Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 1343-1348 Year: 2011 Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Atrial arrhythmias in pulmonary hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Successful multimodality managements of severe pulmonary artery hypertension in pregnancy with VA-ECMO and atrial septostomy using stent Source: International Congress 2019 – CCC Respiratory critical care Year: 2019 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 636s Year: 2004 Low dose intravenous iloprost therapy in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 426s Year: 2006 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension Year: 2019 Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 595-600 Year: 2004 Incidence of atrial fibrillation after lung resection surgery and corelation with right atrial strain Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Successful artocoronary bypass grafting in a patient with severe idiopathic pulmonary arterial hypertension: use of intravenous treprostinil Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006 Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016